Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Januar 2017 16:15 ET | Quelle: Cellect Biotechnology Ltd.

Dr. Yaron Pereg Appointed as New Chief Development Officer

TEL AVIV, Israel, Jan. 30, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology, today announces that it has appointed Yaron...
12. Januar 2017 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications

TEL AVIV, Israel, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology, announces today that it has received a...
09. Januar 2017 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Major Shareholder Buying Shares

TEL AVIV, Israel, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology announces today that it has received notice,...
03. Januar 2017 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer

TEL AVIV, Israel, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells,...
28. November 2016 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results

TEL AVIV, Israel, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells,...
23. November 2016 10:44 ET | Quelle: Cellect Biotechnology Ltd.

Cellect signs agreement with the Hadassah Technological Transfer Company – Hadasit

TEL AVIV, Israel, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Cellect biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP) (hereinafter the “Company”) announces it has signed an agreement with Hadasit, the...
13. September 2016 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Receives Israeli Ministry of Health Approval to Initiate Phase I/II Clinical Trial in Leukemia Patients

Company’s innovative cell selection product may dramatically reduce bone marrow transplantation risks Patient enrollment expected to begin in the next few weeks TEL AVIV, Israel, Sept. 13, 2016 ...
01. September 2016 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter 2016 Financial Results

TEL AVIV, Israel, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem...
25. August 2016 08:00 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. to Present at 18th Annual Rodman & Renshaw Global Investment Conference on September 12, 2016

KFAR SABA, Israel, Aug. 25, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem...
29. Juli 2016 08:47 ET | Quelle: Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

KFAR SABA, Israel, July 29, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (NASDAQ:APOPW) (TASE:CLBD), a developer of innovative technology which enables the functional...

Vorherige Seite